News from prime therapeutics llc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Mar 27, 2023, 09:30 ET Prime Therapeutics announces Mostafa Kamal as president

Prime Therapeutics LLC (Prime), a pharmacy benefit manager (PBM) serving nearly 38 million members nationally, has appointed Mostafa Kamal as...

Mar 16, 2023, 08:00 ET Prime Therapeutics and Magellan Rx to present seven managed care pharmacy research studies at AMCP conference

Leading pharmacy benefit manager (PBM) Prime Therapeutics LLC (Prime) and Magellan Rx Management, (Magellan Rx), a Prime Therapeutics company, will...

Mar 06, 2023, 12:00 ET Prime Therapeutics hires Matt Patella to lead employer account sales and account management

Prime Therapeutics, a pharmacy benefit manager (PBM) serving nearly 38 million members nationally, has hired industry veteran Matt Patella as its new ...

Feb 09, 2023, 08:00 ET Magellan Rx Management earns reaccreditation from the National Committee for Quality Assurance

Magellan Rx Management, LLC (Magellan Rx), a Prime Therapeutics LLC (Prime) company, today announced it was reaccredited by the National Committee...

Jan 25, 2023, 08:00 ET Magellan Rx Management issues seventh Medicaid Pharmacy Trend Report™

Magellan Rx Management (Magellan Rx), a Prime Therapeutics LLC (Prime) company, released its seventh annual Medicaid Pharmacy Trend Report™, the...

Dec 16, 2022, 09:00 ET Prime Therapeutics to retain Humira® alongside biosimilars on NetResults™ formulary in 2023

Leading pharmacy benefit manager (PBM) Prime Therapeutics LLC (Prime) today announced its 2023 Humira® formulary recommendations. In 2023, Prime will ...

Dec 14, 2022, 09:00 ET Medical Pharmacy Trend Report™ delivers insights, forecasting in 12th edition

Magellan Rx Management (Magellan Rx), a Prime Therapeutics LLC (Prime) company, released its 12th annual Medical Pharmacy Trend Report™, featuring a...
Prime Therapeutics closes $1.35 billion Magellan Rx acquisition, uniting pharmacy and medical drug management expertise

Dec 05, 2022, 08:00 ET Prime Therapeutics closes $1.35 billion Magellan Rx acquisition, uniting pharmacy and medical drug management expertise

Leading pharmacy benefit manager (PBM) Prime Therapeutics LLC (Prime) today finalized the previously announced acquisition of Magellan Rx Management, ...

Oct 10, 2022, 09:00 ET Prime Therapeutics Presents Real-world Evidence-based Research

Leading pharmacy benefit manager (PBM) Prime Therapeutics LLC (Prime) used its integrated medical and pharmacy claims data to evaluate the real-world ...

Jul 21, 2022, 09:00 ET Prime Therapeutics recognized as a Disability Equality Index® Best Place to Work for Disability Inclusion

Leading pharmacy benefit manager (PBM) Prime Therapeutics LLC (Prime) is proud to announce its score of 90 on the Disability Equality Index® (DEI),...

Jul 18, 2022, 08:32 ET Prime Therapeutics' intervention pilot for opioid users improves outcomes

During the COVID-19 pandemic, drug overdoses killed over 107,000 Americans in 2021.1 Prior to the pandemic, Prime Therapeutics LLC (Prime), a leading ...

Jun 02, 2022, 09:00 ET Prime Therapeutics finds $1.1 million waste reduction opportunity with medically integrated dispensing compared to central specialty pharmacy

Leading pharmacy benefit manager (PBM) Prime Therapeutics LLC (Prime) analyzed its real-world data to assess clinical outcomes and drug waste...

May 23, 2022, 09:00 ET Prime Therapeutics' MedDrive™ program leverages biosimilars to cut member drug expenses by 26% in one year

Prime Therapeutics LLC (Prime) announced that its MedDrive™ program achieved significant savings in its first year, with biosimilars for treating...

May 05, 2022, 09:00 ET Prime Therapeutics is acquiring Magellan Rx to advance integrated specialty drug management, accelerating efforts to lower the cost of drugs and improve health outcomes

Pharmacy benefit manager Prime Therapeutics LLC (Prime) on May 3 entered into a definitive agreement with Centene Corporation to acquire Magellan...

Apr 11, 2022, 09:02 ET ClearStone Solutions selects Prime Therapeutics as pharmacy benefit manager

Prime Therapeutics LLC (Prime) announced today that they will begin administering Medicare Part D business pharmacy benefits for ClearStone Solutions ...

Feb 25, 2022, 10:00 ET Prime Therapeutics unveils inaugural diversity, equity and inclusion (DEI) transparency report

Leading pharmacy benefit manager (PBM) Prime Therapeutics LLC (Prime) today announces its Diversity, Equity and Inclusion (DEI) Annual Transparency...

Jan 27, 2022, 09:00 ET Prime Therapeutics earns perfect score on Human Rights Campaign Foundation's 2022 Corporate Equality Index

Leading pharmacy benefit manager (PBM) Prime Therapeutics LLC (Prime) proudly announces its top score on the Human Rights Campaign Foundation's 2022...

Jan 20, 2022, 09:07 ET Prime Therapeutics earns re-accreditations from URAC, NCQA

In a demonstration of its commitment to quality health care, Prime Therapeutics LLC (Prime), a leading pharmacy benefit manager (PBM) serving nearly...

Jan 11, 2022, 09:34 ET Prime Therapeutics introduces HighTouchRx™ pharmacist outreach program using both medical and pharmacy data to help maximize savings

Leading pharmacy benefit manager (PBM) Prime Therapeutics LLC (Prime) announces the launch of HighTouchRx™. The award-winning program applies machine ...

Nov 03, 2021, 09:00 ET Prime Therapeutics backs first interchangeable insulin biosimilar Semglee®

Prime Therapeutics LLC (Prime), a leading pharmacy benefit manager (PBM) serving nearly 33 million members, will be preferring Viatris' biosimilar...

Oct 19, 2021, 10:00 ET Going beyond the first fill: Prime Therapeutics, NCODA collaboration enables improved patient outcomes through new oncology pharmacy accreditation

Prime Therapeutics (Prime), a leading pharmacy benefit manager (PBM) serving more than 33 million members, will prefer for its IntegratedRx™ -...

Oct 18, 2021, 11:00 ET Cancer patients, caregivers benefit with integrated clinic-to-pharmacy care through Prime Therapeutics' IntegratedRx™ - Oncology

Prime Therapeutics, a leading pharmacy benefit manager (PBM) serving more than 33 million members, today introduced IntegratedRx™ - Oncology. This...

Oct 14, 2021, 09:02 ET In first of its kind study, Prime Therapeutics explores paroxysmal nocturnal hemoglobinuria (PNH) C5 inhibitor treatment rates

Leading pharmacy benefit manager (PBM) Prime Therapeutics LLC (Prime) used its integrated medical and pharmacy claims data to evaluate paroxysmal...

Oct 06, 2021, 10:00 ET Prime Therapeutics launches new MedsYourWay™ offering, now giving Blue Plan members home delivery prescription option using Amazon Pharmacy

Prime Therapeutics LLC, a leading pharmacy benefit manager, announces its new MedsYourWay™ offering, designed to deliver breakthrough consumer...

Sep 27, 2021, 14:00 ET Prime Therapeutics welcomes Chris Knibb as Chief Financial Officer

Chris Knibb, an accomplished finance executive with more than 25 years of financial and business leadership, has joined Prime Therapeutics LLC...